Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life.
We work with government authorities to ensure patients have access to care while also funding medical research.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
Every day at CSL Behring, we work as if someone’s life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
Make your well-being a priority. It's important and so are you.
CSL’s CEO reflects on the importance of recognizing Rare Disease Day.
This mega-meeting in San Francisco focuses on biotech deals and investors, but rare disease advocates are also seizing the mo…
Around the world, CSL is building creative partnerships with universities and research institutions.
Leaders ring the opening bell in Sydney and reflect on the company’s transformation into a global biotechnology business.
It’s lights, camera, action as CSL chief Paul Perreault films employee messages in our U.S. studio.
Nominations are open for this year’s Junior National Championship.
CEO and Managing Director sits down with NPR affiliate to discuss evolving industry.
CSL CEO Paul Perreault highlights ongoing partnership during PSU appearance.
Why improving access to care is on my mind this February – and every day.
Honored by the Philadelphia Business Journal, Paul Perreault talks about his journey.
Understanding our patients and advancing their access to care is part of our promise.
Popular search terms:
Americas
Asia Pacific
Europe
